Vera Therapeutics (NASDAQ:VERA – Get Rating) had its target price trimmed by HC Wainwright from $15.00 to $11.00 in a research report released on Wednesday, The Fly reports. The firm currently has a buy rating on the stock. HC Wainwright also issued estimates for Vera Therapeutics’ Q1 2023 earnings at ($0.70) EPS, Q2 2023 earnings […]
Vera Therapeutics (NASDAQ:VERA – Get Rating) had its price objective cut by HC Wainwright from $15.00 to $11.00 in a research note issued to investors on Wednesday, The Fly reports. They currently have a buy rating on the stock. HC Wainwright also issued estimates for Vera Therapeutics’ Q1 2023 earnings at ($0.70) EPS, Q2 2023 […]
Should You Buy or Sell Vera Therapeutics Stock? Get The Latest VERA Stock Forecast, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat.